The weekly litigation news digest is live. Subscribe now

IP Verse

Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione - EP3042659

The patent EP3042659 was granted to Celgene on Dec 19, 2018. The application was originally filed on Sep 3, 2004 under application number EP15199521A. The patent is currently recorded with a legal status of "Revoked".

EP3042659

CELGENE
Application Number
EP15199521A
Filing Date
Sep 3, 2004
Status
Revoked
Jul 3, 2020
Publication Date
Dec 19, 2018
External Links
Slate, Register, Google Patents

Patent Summary

The present disclosure generally relates to data communication networks, and more particularly to a method and system for managing network service level agreements in an intelligent networking environment. Modern networked computer environments are evolving to provide service level agreements (SLAs) for network resources and services to customers. A service level agreement (SLA) is a service contract between a service provider and a customer, which describes the type, level, and expected performance of services provided by the service provider. SLAs are typically negotiated between a customer and a service provider to address various service requirements, such as performance, support, reliability, security, availability, or capacity. SLAs may be used to provide differentiated services, such as a guaranteed bandwidth, a guaranteed throughput, or a guaranteed quality of service (QoS), to a network customer. SLAs are typically applied to a network service as a whole, for example, a network connection, such

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BACHELINAug 7, 2019HOFFMANN EITLE -
GENERICS UKAug 7, 2019ELKINGTON AND FIFE -
HAMM & WITTKOPPAug 7, 2019HAMM & WITTKOPP -
HOFFMANN EITLEJul 25, 2019HOFFMANN EITLEADMISSIBLE
PRUSSJul 25, 2019HOFFMANN EITLEADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20030411649
DESCRIPTIONUS20030411656
DESCRIPTIONUS20030438213
DESCRIPTIONUS20030693794
DESCRIPTIONUS20030699154
DESCRIPTIONUS5635517
DESCRIPTIONUS6114335
DESCRIPTIONUS6235756
DESCRIPTIONUS6281230
OPPOSITIONWO9803502
OTHEREP1667682
OTHERWO9803502
SEARCHUS2002045643

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents